secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-01-16T23:59:59+00:00
Accession:  0001213900-24-003691
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals regains Nasdaq minimum bid price compliance
----------------------------------------------------------------------

- Received Nasdaq letter on Jan 10, 2024 confirming compliance with Bid Price Rule 5550(a)(2).
- Closing bid price averaged $1.00 or more for 10 consecutive business days through Jan 9, 2024.
- Previously received deficiency notice on Nov 2, 2023; delisting risk now resolved.
- Company's common stock (SXTP) and warrants (SXTPW) continue trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024003691/0001213900-24-003691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024003691/ea191500-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-003691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer